The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Monday Biotech Deal Review: December 7, 2009

This was a fairly busy week for Canadian biotech deals, including a new brain-y collaboration for MaRS; peace at Patheon; some overallotment and some underallotment; some diversification by Canadian pharma (even if not on quite the scale of Pfizer’s deal with Protalix); and some trans-Atlantic acquisitiveness of a Canadian company’s own devicing [sic., sorry].  Don’t stop now…

Bedfellows

Securities (funny you should call them that)

IPs Passing in the Night (One South-bound and one North-bound license)

  • Dow AgroSciences licensed Vancouver-based Agrisoma’s “Engineered Trait Loci (ETL)” technology [ed. homologous recombination.], though financial terms were not disclosed.  The license is exclusive for major food crops, and non-exclusive for other crop species.
  • Sanofi-aventis Canada is licensing a new kind of epinephrine auto-injector from Intelliject, Inc. (in case your Epi-Pen just isn’t cutting it for you as a way to combat anaphylaxis).  We know there is “an upfront payment and … [possible] future milestone payments and royalties,” but we don’t know how much.  The product development story is pretty good — the injector was invented by highly allergic twins, one who got a masters in systems engineering, and the other got an MD/Ph.D. — and now the story has a good ending I bet (even if the specifics aren’t disclosed).  Sanofi-aventis Canada’s story is good too: Hugh O’Neill, President and CEO says the deal is part of the company’s “diversification strategy…. to move away from the traditional model of a pharmaceutical company into a true patient-centric healthcare solutions provider.”

Imaging That (Radiological Society of North America (RSNA) meeting spurs deals)

Black and Scholes Kidnap Schrodinger’s Cat (uncertainty is optional)

Bookmark and Share

About these ads

One response to “Monday Biotech Deal Review: December 7, 2009

  1. Pingback: Monday Biotech Deal Review: December 14, 2009 « The Cross-Border Biotech Blog

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 126 other followers